WILMINGTON, Del., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has changed the start time of the company’s Innovation Day being held on Tuesday, September 12, 2023. The event will now begin at 9:30 a.m. ET instead of 9:00 a.m. ET for both in-person attendees as well as those
Robin Lampkin named senior vice president, general counsel and secretary WILMINGTON, Del., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced that its board of directors has approved the appointment of Robin Lampkin as senior vice president, general counsel and secretary.
WILMINGTON, Del., Aug. 14, 2023 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.385 cents per share on the company's common stock. The dividend is payable on September 15, 2023, to stockholders of record at the close of business on
Wilmington, Del., August 2, 2023 - Ashland has launched iSolve ™ pharma, a pharmaceutical customer portal where customers can easily access robust information about the company’s pharmaceutical offerings and other important related business material such as our most recent innovations, literature,
WILMINGTON, Del., July 27, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a live Innovation Day on Tuesday, September 12, 2023 beginning at 9:00 a.m. ET at the company’s corporate headquarters in Wilmington, Delaware. Interested participants must register for the event and have the
Sales of $546 million, down 15 percent compared to the prior-year quarter Net income (including discontinued operations) of $50 million, or $0.94 per diluted share Income from continuing operations of $42 million, or $0.79 per diluted share Adjusted income from continuing operations excluding
WILMINGTON, Del., July 14, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fiscal-third quarter earnings release at approximately 5 p.m. ET on Tuesday, July 25, 2023. The company’s live webcast with securities analysts will include an executive summary and
Registration for limited seating open now WILMINGTON, Del., July 6, 2023 – Ashland is collaborating with The Pii Center for Pharmaceutical Technology, University of Mississippi School of Pharmacy, to present The Advanced Hands-on Course in Tablet Technology at the Ashland state-of-the-art
WILMINGTON, Del., June 28, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today provided an update for preliminary fiscal 2023 third-quarter financial results 1 and its outlook for fiscal year 2023 results. The global additives and specialty ingredients company holds leadership positions in
Jay V. Ihlenfeld and Brendan M. Cummins plan exit in January 2024 WILMINGTON, Del., June 26, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced the appointment of Sergio Pedreiro, former chief operating officer, Revlon, to its Board of Directors, effective July 1, 2023. Jay V.